VARUNÉ Labs
Ambition, governed.
VARUNÉ Labs is a proposed medicines development venture and Scottish campus programme led by Varun Sharma. It is being shaped around formulation-led science, possible use of qualified external providers, evidence ownership, disciplined capital and a long-term option to create shared infrastructure in Scotland.
Precision before publicity
Public language should never travel ahead of documentary control, approvals or current operational evidence.
Partnership before footprint
Qualified external capability protects runway while the right scientific and commercial control position is established.
Permission to stop
Every campus and programme decision must retain a credible pause, shrink, change sequence or kill route.
Founder
Meet Varun Sharma.
Read the evidence-led principles guiding VARUNÉ Labs and the proposed Scottish campus.
Meet the founderLocation discipline
Scotland is preferred. The decision remains evidence-led.
If the Scottish site case does not converge, VARUNÉ could pause fixed infrastructure and open a fresh comparator process. Any authorised specialist work would remain external and use qualified providers. Another United Kingdom cluster would be the first logical review, with selected European reference markets considered only if a wider process were authorised.
This section does not represent an active alternative location search, site discussion, negotiation, relocation decision or international campus. It illustrates how any future comparison would be governed.
Review the governed location sequenceGovernance boundary
Website operations are defined. Future delivery is not.
NEUVIOR Pharmaceuticals Ltd operates this website and the current predevelopment programme. The legal sponsor, project vehicle, site, funding and delivery structure for any future campus remain subject to board, adviser and counterparty confirmation.